Kestra Medical Technologies (NASDAQ:KMTS) Shares Gap Up – Here’s What Happened

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS)’s share price gapped up before the market opened on Friday . The stock had previously closed at $24.91, but opened at $26.45. Kestra Medical Technologies shares last traded at $27.15, with a volume of 105,572 shares traded.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on KMTS. Wall Street Zen downgraded shares of Kestra Medical Technologies from a “hold” rating to a “sell” rating in a report on Sunday, September 28th. BTIG Research initiated coverage on shares of Kestra Medical Technologies in a research note on Tuesday, November 18th. They issued a “buy” rating and a $32.00 target price for the company. Piper Sandler increased their price target on Kestra Medical Technologies from $27.00 to $30.00 and gave the stock an “overweight” rating in a research report on Friday. Wells Fargo & Company reaffirmed an “overweight” rating and set a $28.00 price target on shares of Kestra Medical Technologies in a report on Friday. Finally, Weiss Ratings reissued a “sell (d)” rating on shares of Kestra Medical Technologies in a research note on Wednesday, October 8th. Six equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Kestra Medical Technologies has an average rating of “Moderate Buy” and a consensus target price of $28.57.

Kestra Medical Technologies Stock Up 6.3%

The firm’s 50-day moving average is $25.51 and its two-hundred day moving average is $20.78. The company has a debt-to-equity ratio of 0.23, a quick ratio of 6.84 and a current ratio of 6.84. The stock has a market cap of $1.36 billion and a P/E ratio of -10.39.

Kestra Medical Technologies (NASDAQ:KMTS) last released its earnings results on Thursday, September 11th. The company reported ($0.50) EPS for the quarter, beating the consensus estimate of ($0.66) by $0.16. The firm had revenue of $19.37 million during the quarter, compared to analyst estimates of $17.68 million.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. Quarry LP bought a new stake in Kestra Medical Technologies in the first quarter valued at approximately $33,000. China Universal Asset Management Co. Ltd. acquired a new position in shares of Kestra Medical Technologies in the 3rd quarter valued at $48,000. Police & Firemen s Retirement System of New Jersey bought a new stake in shares of Kestra Medical Technologies in the 2nd quarter valued at $54,000. BNP Paribas Financial Markets raised its stake in Kestra Medical Technologies by 148.9% during the 3rd quarter. BNP Paribas Financial Markets now owns 2,738 shares of the company’s stock worth $65,000 after buying an additional 1,638 shares during the period. Finally, Brown Brothers Harriman & Co. lifted its holdings in Kestra Medical Technologies by 26.8% during the third quarter. Brown Brothers Harriman & Co. now owns 3,104 shares of the company’s stock worth $74,000 after acquiring an additional 656 shares in the last quarter.

Kestra Medical Technologies Company Profile

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.